Alkhalaf et al. (23) |
RCTs |
Benfotiamine (e) or placebo (c) |
Netherlands, 1 outpatient clinic |
86 males: 39 (e) 43 (c); age: 40–75 years Health status: T2DM, UAE |
12 weeks |
Hs-CRP, serum amyloid A (sAA), myeloperoxidase (MPO) |
Diabetic nephropathy |
Intervention insignificant on chronic low-grade inflammation |
All p > 0.05 |
Choi et al. (24) |
RCTs |
Exercise (e) and control (c) groups |
Korea, 1 School of Medicine |
80 Females: 38 (e) 37 (c), age: 54.4 ± 6.6 years Health status: T2DM, <2 kg, sedentary lifestyle |
12 weeks |
sRAGE, Hs-CRP, IL-6 |
Vascular complications, cardiometabolic risk |
Decreased hs-CRP, IL-6, waist circumference, systolic and diastolic blood pressure, HbA1c, glucose, AST, apolipoprotein B, and free fatty acid |
sRAGE to Hs-CRP (p = 0.019; r = −0.27) |
Homayouni et al. (25) |
RCTs |
Hesperidin supplement or placebo |
Iran, 1 University Medical Clinic |
Total: 64; Male: Female: Age: 30–65 years Health status: T2DM, BMI <30 |
6 weeks |
TNF-α, IL-6, hs-CRP, total anti-oxidant capacity (TAC) |
Vascular complications |
Reduced levels of inflammatory markers |
IL-6 (p = 0.001) and hs-CRP increased (p < 0.000), TAC (p < 0.000) decreased |
Schell et al. (26) |
Randomized crossover study |
Dietary raspberries |
USA, 1 Clinical Assessment Unit |
Total: 25 Male: 5 Female: 20 Age: 54 ± 4.2 years Health status: T2DM, waist circumference (men: >102, women: >89 cm) |
2 days postprandial phase 1 week apart A 1-week washout phase. 10-week “diet supplement phase” of 4 weeks with 2 weeks apart |
(IL)-6 and hs-TNF-α |
Vascular complications |
Red raspberries significantly improved postprandial hyperglycemia and selected markers of inflammation |
All p > 0.05 |
Barzilay et al. (27) |
RCTs |
Salsalate |
USA |
Total: 227 ≥75 years Male: 130 Female: 97 Health status: T2DM, HBA1c: 7–9.5 |
48 weeks |
CRP, TNF-α, WBC types |
Vascular complications |
Lowered HbA1c, reduction in WBC, neutrophil, and lymphocyte counts indicated anti-inflammatory role. Changes in furosine was positive with CRP and TNF changes but not other glycation products |
p > 0.05 for CRP and TNF for furosine changes in salsalate users |
Kadoglou et al. (28) |
RCTs |
Aerobic training program (exercise) |
Greece |
Total: 60 Male: 26 Female: 34 Age: 61.64 ± 4.9 years Health status: T2DM, obese, HBA1c: 6.5–8.5, no diabetic angiopathy, postmenopausal women |
6 months (four times/week, 45–60 min/session) |
hs-CRP, IL-10, IL-18, TNF-α |
Cardiovascular risk, without vascular complications |
Exercise training improved metabolic profile and exerts anti-inflammatory effects in T2DM |
Reduced CRP (p = 0.04) and IL-18 (p = 0.02). Increased IL-10 (p = 0.039); suppressed IL-18/IL-10 ratio (p = 0.014) |
Krysiak et al. (29) |
RCTs |
Simvastatin, fenofibrate, simvastatin + fenofibrate, and placebo |
Poland, 1 large Teaching Hospital |
Total: 190 Age: 25–75 years Male: 108 Female: 82 Health status: untreated T2DM |
180 days−90 days lifestyle modification and 90 days for the intervention |
TNF, IL-1, IL-2, IL-6, MCP-1, plasma C reactive protein levels |
Systemic inflammation, atherogenic dyslipidemia |
Simvastatin and fenofibrate decreased monocyte release of TNF, IL-1, IL-2, IL-6, MCP-1, and lymphocyte release of IL-2, plasma C reactive protein levels. Anti-inflammatory effects of fenofibrate partly correlated with the improvement in insulin sensitivity |
All significant (p = 0.001), but weakly correlated for fenofibrate alone on hs-CRP (r = 0.20 to 0.29, p = 0.001) |
Zarezadeh et al. (30) |
RCTs |
Ginger powder and wheat flour |
Iran, 1 large Teaching Hospital |
Total: 48 Age: 30–60 years (both genders) Male: Female: Health status: T2DM b/w 1 and 10 years |
10 weeks |
Intercellular adhesion molecule 1 (ICAM-1) |
Vascular complications, cardiovascular disease |
Ginger supplementation decreased sICAM-1 and ADMA after intervention but was marginally significant |
Ginger supplement decreased sICAM-1 marginally (p = 0.097) |
Mizoguchi et al. (31) |
RCTs |
31 pioglitazone-treated and 21 glimepiride-treated patients. Serial 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) imaging |
Japan, 1 large Teaching Hospital |
Total: 56 Age: 60–76 years Male: 39 Female: 13 Health Status: T2DM |
4 months |
hs-CRP |
Impaired glucose tolerance, atherosclerotic plaque inflammation |
High-sensitivity C reactive protein was decreased by pioglitazone, whereas it was increased by glimepiride |
h-CRP levels decreased by pioglitazone (P < 0.01) but increased marginally by glimepiride(p < 0.05) |